clinical research services
WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business
WuXi AppTec; Hillhouse Capital; divestment; clinical research services; CRDMO; manufacturing; China; WuXi Clinical; MedKey